An interventional study of C2Rx and Standard of Care (SOC) in Continuous Renal Replacement Therapy, Pulmonary Edema and COVID-19, sponsored by SeaStar Medical. Withdrawn. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-12-14.
Sponsored by SeaStar Medical · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The clinical trial will evaluate the short term and extended impact on on respiration, pulmonary function and cardiovascular function in C2Rx treatment verse Standard of Care (SOC) in critically ill adults with COVID-19 infections .
127 studies on the registry are indexed under Pulmonary Edema; 28 are open to participants now.
Browse Pulmonary Edema studies →SeaStar Medical is the lead sponsor of 7 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hemofiltration device
Device: C2Rx
Standard of Care based on protocol inclusion/exclusion criteria
Other: Standard of Care (SOC)
Hemofiltration
Standard of care that excludes any protocol restrictions.
Pulmonary Oxygenation Function
Change in patient Arterial Oxygen Partial Pressure (PaO2)/Fractional Inspired Oxygen (FiO2) Ratio
Time frame: Up to 72 hours
Pulmonary Compliance of Respiratory System (CRS)
Change in patient oxygenation
Time frame: Up to 96 hours
Survival
Change in the total number of patients that survived
Time frame: 30 days and 60 days
Hospital Costs 1
Change in Hospital Utilization of ventilators (days)
Time frame: Out to 60 days
Cardiovascular Vasoactive-Inotropic Score (VIS)
Change in score based on the calculation of the following medications used: dopamine dose (µg/kg/min) + dobutamine dose (µg/kg/min) + 100 x adrenaline dose (µg/kg/min) + 100 x noradrenaline dose (µg/kg/min) + 10 x milrinone dose (µg/kg/min) + 10.000 x vasopressin dose (U/kg/min)
Time frame: Up to 96 hours
Hospital Costs 2
Change in Hospital Utilization of vasopressor medication (days without use)
Time frame: Out to 60 days
Hospital Costs 3
Change in Hospital Utilization of Intensive Care Unit (ICU) Hospital free days
Time frame: Out to 60 days
Hospital Costs 4
Change in Hospital Utilization of Renal Replacement Therapy (days on therapy)
Time frame: Out to 60 days
Hospital Costs 5
Change in Hospital Utilization (days hospitalized)
Time frame: Out to 60 days
Inflammatory mediators in blood
Changes in inflammatory mediators detected by Immunoassay of Multianalyte Panel - MAP Laboratory Panel of 253 analytes.
Time frame: Out to 14 hours
Cytokine Sieving Effects
Change in cytokine levels obtained from plasma and blood collected prior to and after filter. Analyte concentrations in ultrafiltrate and plasma, expressed in the same concentration units, will be aggregated as a ratio of ultrafiltrate concentration to plasma concentration to yield a unitless Sieving Coefficient (SC). SC is an index of membrane function.
Time frame: Out to 8 hours
Specific Blood Indicators 1
Change in blood Ferritin (mg/mL)
Time frame: Out to 14 hours
Specific Blood Indicators 2
Change in blood Interleukin-6 (pg/mL)
Time frame: Out to 14 hours
Specific Blood Indicators 3
Change in blood C-reactive protein (CRP) (mg/L)
Time frame: Out to 14 hours
Specific Blood Indicators 4
Change in blood Lactate Dehydrogenase (LDH) (U/L)
Time frame: Out to 14 hours
Specific Blood Indicators 5
Change in blood D-dimer (mcg/L\*FEU2)
Time frame: Out to 14 hours
Specific Blood Indicators 6
Change in blood White Blood Cell (WBC) count (%)
Time frame: Out to 14 hours
Specific Blood Indicators 7
Change in blood Neutrophil count (%)
Time frame: Out to 14 hours
Specific Blood Indicators 8
Change in blood lymphocyte count (%).
Time frame: Out to 14 hours
Hospital Acquired Infections (HAI) /Sepsis
Change in the duration of days of diagnosed HAI/ Sepsis infections
Time frame: 30 and 60 days
Composite Recovery
Duration without Respiratory Replacement Therapy (RRT), ventilator, and time to discharge
Time frame: Up to 30 days
Composite Survival
Survival without Respiratory Replacement Therapy (RRT), ventilator, or time to Long Term Care (LTC)
Time frame: 30 and 60 days
Composite Non-Recovery
Survival with Respiratory Replacement Therapy (RRT), ventilator or in Long Term Care (LTC)
Time frame: Up to 60 days
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2020; primary completion for Nov 2020, 2 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SeaStar Medical